Fears and Phobias

Understanding specific phobias, social anxiety, agoraphobia, and panic disorder, with evidence-based treatment at Phuket Island Rehab.

Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician and Addiction Medicine Specialist, Phuket Island Rehab.

A phobia is an intense, persistent, irrational fear of a specific object, situation, animal, or activity that produces immediate anxiety and leads to avoidance behavior. Specific phobias affect 7 to 12 percent of adults at some point in life and are the most common anxiety disorder in many countries. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders defines four major phobia-related conditions: specific phobia, social anxiety disorder, agoraphobia, and panic disorder, each with its own diagnostic criteria, treatment approach, and overlap with depression and substance use. Treatment is highly effective and is built around exposure therapy, cognitive behavioral therapy, and where appropriate selective serotonin reuptake inhibitors. At Phuket Island Rehab, our clinical team treats phobias and panic alongside the alcohol use disorder, substance use, or trauma that often co-occurs with them, in a residential setting that provides time and structure for the therapy to work.

What is a phobia?

A phobia is an intense, persistent, and irrational fear of a specific object or situation, an animal, an activity, or a social setting, that produces immediate anxiety on exposure and which leads the person to avoid the trigger. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders distinguishes between several specific phobia-related conditions, each with its own diagnostic criteria and treatment approach. A specific phobia is a discrete fear of a particular object or situation, such as snakes, spiders, heights, flying, blood, or medical procedures. Social anxiety disorder is a persistent fear of social or performance situations in which the person worries about being judged. Agoraphobia is a fear of public spaces, of being in a situation from which escape might be difficult, or of being alone outside the home. Panic disorder is characterised by recurrent unexpected panic attacks and a persistent worry about further attacks. All four conditions involve intense anxiety in response to a feared trigger, avoidance behavior to manage the anxiety, and significant impact on daily life.

Fears are common and not all fears are phobias. A reasonable wariness of snakes, a moderate dislike of public speaking, and a sensible caution at heights are normal human experiences that do not meet criteria for a clinical phobia. A phobia is distinguished by the intensity of the response, the extent to which the person actively avoids the feared situation, the impact on daily life, and the person’s own recognition that the fear is out of proportion to the actual danger. The line between strong dislike and clinical phobia is set by the impact on the person’s life rather than by the content of the fear, and a person who is moderately afraid of spiders but who copes with the occasional encounter without distress does not meet criteria for arachnophobia. A person who reorganises their daily life around avoidance of any situation where a spider might appear, who experiences immediate anxiety on seeing a picture of a spider, and who has not been to a park for years does.

Specific phobias

Specific phobia is the most common anxiety disorder in many national surveys, with lifetime prevalence estimates of 7 to 12 percent in adults and somewhat higher in adolescents. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders groups specific phobias into five categories: animal phobias including fears of dogs, snakes, spiders, and insects; natural environment phobias including heights, water, and storms; blood-injection-injury phobias including fears of needles, medical procedures, and the sight of blood; situational phobias including fears of flying, driving, enclosed spaces, and elevators; and other specific phobias including fears of choking, vomiting, or specific medical conditions. The pattern of physical and psychological response is broadly similar across the categories, but blood-injection-injury phobias have a distinct pattern of initial sympathetic arousal followed by a vasovagal response, with fainting, which the other categories do not show.

The age of onset for specific phobias is typically in early childhood for animal phobias and in adolescence or early adulthood for situational phobias. Many specific phobias begin after a single frightening experience, but a substantial proportion develop without a clear trigger. Specific phobias often go untreated for years, partly because the avoidance pattern allows the person to function around the fear and partly because the fear becomes integrated into the person’s identity. People with multiple specific phobias, or with specific phobia plus another anxiety disorder, are more likely to seek treatment and more likely to have associated alcohol use disorder or substance use disorder as a means of managing the broader anxiety picture.

Social anxiety disorder

Social anxiety disorder, sometimes called social phobia, is a persistent fear of social situations in which the person worries about being judged or humiliated. The condition extends beyond the ordinary nervousness most people feel before a presentation or a first date. People with social anxiety disorder experience intense anxiety in everyday social interactions, often anticipate negative judgment from others even when there is no basis for it, and avoid social situations whenever possible. The condition typically begins in adolescence, persists for years if untreated, and substantially affects work, relationships, and overall quality of life. Lifetime prevalence is 7 to 13 percent in most national surveys, with women diagnosed at higher rates than men, though men may be under-diagnosed because they more often self-medicate with alcohol.

Social anxiety disorder is one of the most strongly linked anxiety disorders to alcohol use disorder. People with social anxiety disorder are several times more likely than the general population to develop problem drinking, often because drinking initially helps with the social discomfort and then becomes a learned response that is difficult to stop. Patients who present with alcohol use disorder and severe social discomfort often have undiagnosed social anxiety disorder underneath, and the treatment plan needs to address both conditions if either is to be resolved. People often experience their social anxiety as a personality trait rather than a treatable condition, which is one reason it goes unrecognised for so long.

Agoraphobia

Agoraphobia is the fear of being in a situation from which escape might be difficult or in which help would not be available if a panic attack occurred. Common feared situations include public spaces, public transport, shopping centres, crowded places, queues, and being outside the home alone. The condition can become severe enough that the person becomes housebound. Agoraphobia is closely linked to panic disorder, with around half of people with agoraphobia also experiencing recurrent panic attacks, although the conditions are listed separately in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders. The lifetime prevalence of agoraphobia is 1 to 3 percent in most national surveys, with women diagnosed at higher rates than men.

Agoraphobia typically develops in late adolescence or early adulthood, often after one or several panic attacks. The avoidance behavior is the central problem, and the person’s life shrinks over months and years as they avoid more and more places. Without treatment, the condition tends to be chronic and disabling. With treatment, particularly exposure therapy and where appropriate selective serotonin reuptake inhibitors, the great majority of patients improve substantially. Agoraphobia is over-represented in patients with comorbid alcohol use disorder or benzodiazepine dependence, with both substances often used to manage the anxiety of leaving home.

Panic disorder

Panic disorder is characterised by recurrent unexpected panic attacks and a persistent worry about future attacks. A panic attack is an abrupt surge of intense fear or discomfort that reaches a peak within minutes and includes physical symptoms such as racing heart, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, derealisation, and a fear of losing control or dying. The physical symptoms are intense enough that many people having their first panic attack present to emergency departments believing they are having a heart attack. After the first attack, many people develop a persistent fear of having another attack, and the anticipatory anxiety itself becomes a substantial source of distress and impairment. Panic disorder has a lifetime prevalence of 2 to 5 percent, with onset typically in late adolescence or early adulthood.

Panic disorder is closely linked to other anxiety conditions and to depression, and is over-represented in patients with substance use disorders. Alcohol and benzodiazepines are commonly used to manage the anticipatory anxiety and to prevent panic attacks. Stimulant use, including caffeine, cocaine, and methamphetamine, can trigger panic attacks in vulnerable individuals and can complicate the differential diagnosis of new-onset panic. Treatment of panic disorder includes cognitive behavioral therapy with interoceptive exposure, in which the patient is gradually exposed to the physical sensations of panic in a controlled setting until they no longer trigger fear, and where appropriate selective serotonin reuptake inhibitors or venlafaxine.

How fears and phobias develop

Several factors contribute to the development of fears and phobias. Genetic factors account for around 30 to 40 percent of the variance in phobia risk in twin studies. Temperamental factors, particularly behavioral inhibition in childhood, are associated with higher risk of all anxiety disorders. Specific learning experiences, including traumatic events, witnessing fearful behavior in parents, and verbal warnings about specific threats, all contribute to the development of phobias. Brain circuit factors, particularly the activity of the amygdala and the connections between the amygdala and the prefrontal cortex, are involved in the threat detection that becomes overactive in phobic conditions. The end result is that the fear circuit becomes sensitised to a specific trigger, and the avoidance behavior that protects the person from the trigger also prevents the natural extinction of the fear that exposure would otherwise produce.

Avoidance is the engine that keeps phobias going. Every time the person avoids the feared situation, they experience an immediate reduction in anxiety, which negatively reinforces the avoidance and strengthens the pattern. The brain never gets the chance to learn that the feared object or situation is not dangerous, because the person never stays in the situation long enough for the anxiety to subside. Effective treatment, particularly exposure therapy, deliberately interrupts this cycle by keeping the person in contact with the feared trigger until the anxiety begins to subside, which produces the new learning that the trigger does not lead to the catastrophic outcome the fear predicted.

Evidence-based treatment for fears and phobias

Phobias respond well to evidence-based therapy. Exposure therapy, in which the patient is gradually exposed to the feared trigger under structured conditions until the anxiety subsides, is the most effective treatment for specific phobia, with success rates above 80 percent for most specific fears. Cognitive behavioral therapy combines exposure with cognitive work on the threat appraisals that drive the fear, and is the first-line treatment for social anxiety disorder, agoraphobia, and panic disorder. The therapy typically runs across 8 to 16 weekly sessions, with home practice between sessions to consolidate the new learning. Newer approaches including acceptance and commitment therapy, mindfulness-based interventions, and virtual reality exposure are also evidence-supported.

Pharmacotherapy is used as an adjunct or alternative to therapy in some patients. Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors are first-line medications for social anxiety disorder, panic disorder, and agoraphobia, with paroxetine, sertraline, escitalopram, and venlafaxine the most commonly prescribed. Benzodiazepines may be used for short-term symptomatic relief in severe cases but are not generally recommended for long-term use because of dependence risk, withdrawal complications, and the way the medication interferes with the new learning that exposure therapy needs to produce. Patients with comorbid alcohol use disorder or benzodiazepine dependence need particular care in medication selection, with non-benzodiazepine options preferred wherever possible.

Phobias, alcohol use disorder, and substance use

Fears and phobias and alcohol use disorder are closely linked. Social anxiety disorder, panic disorder, and agoraphobia are all over-represented in patients with alcohol use disorder, and alcohol use disorder is over-represented in patients with these anxiety conditions. The link runs in both directions. People with social anxiety disorder often discover that alcohol reduces their social discomfort, and the drinking becomes a learned response that is difficult to stop. People with chronic heavy drinking often develop anxiety symptoms during periods of reduced drinking, and the anxiety becomes a reason to drink more. The two patterns reinforce each other over months and years.

Treating only the alcohol use disorder, without addressing the underlying social anxiety or panic disorder, leaves the patient vulnerable to relapse the next time the anxiety returns. Treating only the anxiety, without addressing the alcohol use, leaves the patient with a substance pattern that interferes with sleep, with medication response, and with the therapy work. Integrated dual diagnosis treatment, addressing both conditions together, is the standard of care and is associated with measurably better outcomes than sequential treatment. Patients who arrive at our clinic with alcohol use disorder and an underlying fear or phobia leave with both conditions treated together rather than as separate problems.

Treatment at Phuket Island Rehab

Treatment for fears and phobias at our clinic is integrated with the substance use treatment that almost always accompanies them. The first task at admission is a comprehensive assessment that identifies the specific anxiety conditions, the substance use pattern, the trauma history that often sits underneath, and the medication picture that may need adjustment. Patients commonly arrive on a combination of antidepressants and benzodiazepines that may have helped at first but that have come to interfere with the therapy work. The medical and medication review is part of the early stabilisation, and the therapy planning follows once the picture is clear.

The therapy itself draws on cognitive behavioral therapy, exposure therapy, and acceptance and commitment therapy as appropriate to the individual case. Patients with social anxiety disorder work on the social situations they have been avoiding, supported by group therapy that provides the controlled social exposure their treatment needs. Patients with specific phobia work on the specific triggers, with graded in vivo exposure or virtual reality where appropriate. Patients with agoraphobia work on a graded return to public spaces, supported by therapist accompaniment in the early stages. Patients with panic disorder work on interoceptive exposure, learning that the physical sensations of panic are not dangerous and do not have to be avoided. The work is structured around clear weekly targets, supported by home practice and by the residential structure that ensures the work continues even on hard days.

Substance use treatment runs in parallel from day one. Patients with alcohol use disorder receive structured medical detox where appropriate, followed by the same dual diagnosis treatment framework that any other patient with co-occurring substance use and mental health conditions would receive. Treatment options include medical detox, residential rehabilitation, partial hospitalisation, and intensive outpatient programs, with the level of care matched to the severity of both the substance use and the anxiety conditions.

Why international clients come to Thailand

Patients from the United States, the United Kingdom, Australia, and continental Europe travel to Phuket Island Rehab for integrated treatment of phobias, panic, and co-occurring alcohol or substance use disorder. The first reason is the difficulty of accessing integrated dual diagnosis treatment in many home health systems, where anxiety services and addiction services often sit in different parts of the system and rarely coordinate well. The second is privacy: many patients have hidden their phobias and their drinking from family, employers, and even clinicians, and the residential setting allows the work to happen without exposure to the home environment. The third is the residential continuum of care, with medical care, therapy, and aftercare planning happening in one continuous program.

The cost of a full residential programme in Phuket, including therapy, medical care, accommodation, food, and excursions, is a fraction of the equivalent domestic programme for the same level of integrated care. The Phuket setting, the climate, and the distance from the home environment make it materially easier to engage in the exposure work that effective phobia treatment requires, partly because the home cues and avoidance patterns are interrupted. Patients who would have struggled to attend therapy reliably at home find that the residential structure makes the work possible in a way that domestic outpatient services have not.

When the anxiety is interfering with life

Many of the people who reach out to our team are not in obvious crisis. They are still working, still in their relationships, still managing the surface of their lives. What has changed is that the fears and phobias have started to organise daily decisions in ways the person did not consciously choose. The patient who has not been on a plane for years because of flying anxiety, who declines social invitations to avoid social anxiety, who plans every outing around proximity to the home in case of panic, or who drinks before every social event to manage social discomfort is on a pattern that does not stay stable. The pattern usually narrows further over time. If you or someone you love is in this position, the next step is a conversation with a clinician who treats phobias and any associated substance use together.

Heavy drinking is the most common substance pattern in patients with fears and phobias, and alcohol use disorder is the most common substance diagnosis in our residential programme. The two patterns reinforce each other, and treatment that addresses both produces better outcomes than treatment of either alone. Patients who are honest about both, even when the drinking has been a private response to the anxiety, generally do well. The clinical conversation is non-judgemental and grounded in the recognition that the drinking made sense to the patient at the time it began. The work of recovery is to address both the anxiety and the substance pattern so that neither needs the other anymore.

Summary

Fears and phobias are common, treatable, and frequently linked to substance use disorders. Specific phobia, social anxiety disorder, agoraphobia, and panic disorder all involve intense anxiety in response to a feared object or situation, avoidance behavior that maintains the pattern, and significant impact on daily life. Evidence-based treatment is highly effective: exposure therapy, cognitive behavioral therapy, and where appropriate selective serotonin reuptake inhibitors produce substantial improvement in the great majority of patients. The link with alcohol use disorder is strong, and integrated dual diagnosis treatment that addresses both the anxiety condition and the substance use is the standard of care. A residential setting, parallel therapy for both conditions, and a clear aftercare plan are the components of a recovery that lasts beyond the initial improvement.

As our counsellor Dr. Ponlawat Pitsuwan puts it, “Phobias are some of the most rewarding conditions to treat, because the evidence base is strong, the work is structured, and most patients see substantial improvement within weeks of starting properly delivered exposure therapy. What gets in the way is usually not the phobia; it is the alcohol or benzodiazepine the patient has been using to avoid the work. Addressing both together is how we make the therapy actually possible.”

Frequently asked questions about fears and phobias

What is the difference between a fear and a phobia?

A fear is a normal human response to a perceived threat. A phobia is an intense, persistent, and irrational fear of a specific object or situation that produces immediate anxiety on exposure, leads to avoidance behavior, and significantly affects daily life. The line between fear and phobia is set by the intensity of the response, the extent of avoidance, and the impact on the person’s life. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders sets out specific criteria for phobia diagnosis, including duration of at least six months and significant distress or impairment.

What are the most common phobias?

The most common specific phobias include fears of spiders, snakes, heights, flying, enclosed spaces, blood, needles, public speaking, vomiting, and dogs. Social anxiety disorder is one of the most common phobia-related conditions overall, affecting 7 to 13 percent of adults at some point in life. Agoraphobia is less common, with lifetime prevalence of 1 to 3 percent. Panic disorder affects 2 to 5 percent of adults. The categories overlap, and many people meet criteria for more than one condition.

Can phobias be cured?

Phobias respond well to evidence-based treatment. Exposure therapy produces substantial improvement in 80 percent or more of patients with specific phobia, often within weeks of starting properly delivered treatment. Cognitive behavioral therapy is the first-line treatment for social anxiety disorder, agoraphobia, and panic disorder, with response rates of 60 to 75 percent across studies. Selective serotonin reuptake inhibitors are also effective for these conditions and can be used alongside or instead of therapy. While complete elimination of all anxiety is not always realistic, most patients achieve substantial improvement in the symptoms and the impact on daily life.

How does alcohol affect phobias and panic?

Alcohol initially reduces anxiety and is often used by people with social anxiety, panic disorder, and other phobia-related conditions to manage symptoms. Over time, the relationship becomes more complicated. Heavy or regular drinking is associated with worsening anxiety symptoms during periods of reduced drinking, with rebound anxiety on the day after drinking, with disturbed sleep that worsens anxiety, and with the development of alcohol use disorder. Patients with phobia-related conditions are several times more likely than the general population to develop problem drinking, and the two conditions reinforce each other. Effective treatment addresses both.

How is exposure therapy done?

Exposure therapy involves gradual, structured exposure to the feared object or situation under therapeutic supervision. The patient and therapist build a hierarchy of feared situations from least to most anxiety-provoking, and the patient works through the hierarchy in graded steps. Each exposure continues until the anxiety begins to subside on its own, which is the moment of new learning. The patient practices between sessions, and the therapist supports the patient through the difficult moments. Exposure can be in vivo, with real-world exposure to the feared trigger, imaginal, with structured imagination of the trigger, or virtual reality, with computer-simulated exposure. All three approaches have evidence support.

Are benzodiazepines a good treatment for phobias?

Benzodiazepines provide short-term symptomatic relief of anxiety but are not generally recommended for long-term treatment of phobia-related conditions. The medications interfere with the new learning that exposure therapy needs to produce, mean that the patient does not experience the therapeutic anxiety subsiding on its own, and carry the risks of dependence, withdrawal, cognitive impairment, and falls in older adults. Selective serotonin reuptake inhibitors are first-line pharmacotherapy for social anxiety disorder, panic disorder, and agoraphobia. Benzodiazepines may be used for acute severe symptoms but not as ongoing treatment. Patients with comorbid alcohol use disorder need particular care because the combination of benzodiazepines and alcohol is especially risky.

Sources

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5-TR). https://www.psychiatry.org/psychiatrists/practice/dsm

National Institute of Mental Health (NIMH). Anxiety Disorders. https://www.nimh.nih.gov/health/topics/anxiety-disorders

National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder. https://www.nice.org.uk/guidance/cg113

World Health Organization. ICD-11 Anxiety and Fear-Related Disorders. https://icd.who.int

Substance Abuse and Mental Health Services Administration (SAMHSA). Co-occurring disorders. https://www.samhsa.gov

Foa EB, Hembree EA, Rothbaum BO. Prolonged Exposure Therapy. Oxford University Press.

Mineka S, Zinbarg R. A contemporary learning theory perspective on the etiology of anxiety disorders. American Psychologist.

Fears and phobias: clinical context

Fears and phobias affect many people across age groups and may include specific phobias, social anxiety disorder, agoraphobia, and panic disorder. Common features of phobias often include intense anxiety in response to a feared object situation, avoidance behavior, and significant impact on daily life. People with phobias often experience symptoms including racing heart, sweating, trembling, shortness of breath, dizziness, and a strong urge to escape the situation. Therapy and cognitive behavioral therapy are effective treatments for phobia-related disorders. People with a history of substance use disorder, including alcohol use disorder, are more likely to develop phobia-related symptoms, and people with phobias are more likely to develop substance use disorders. Help with phobias is most effective when it includes evidence-based therapy alongside any treatment for co-occurring mental health conditions or substance use. Common phobias including agoraphobia, social anxiety, and panic disorder can develop in late adolescence or early adulthood, often after one or more frightening experiences. Public spaces, crowded places, and situations with extreme intense anxiety are commonly avoided. People often learn to manage their phobia with structured exposure therapy and where appropriate medication.

Fears and phobias — key entities and related terms

Fears, phobias, specific phobia, social anxiety disorder, social phobia, agoraphobia, panic disorder, DSM-5, animal phobia, natural environment phobia, blood-injection-injury phobia, situational phobia, lifetime prevalence, age of onset, behavioral inhibition, amygdala, prefrontal cortex, threat detection, avoidance behavior, exposure therapy, cognitive behavioral therapy, CBT, in vivo exposure, imaginal exposure, virtual reality exposure, acceptance and commitment therapy, mindfulness, selective serotonin reuptake inhibitor, SSRI, serotonin-norepinephrine reuptake inhibitor, paroxetine, sertraline, escitalopram, venlafaxine, benzodiazepines, panic attack, anticipatory anxiety, derealisation, depersonalisation, interoceptive exposure, alcohol use disorder, AUD, dual diagnosis, residential rehab, Phuket Island Rehab, Dr. Ponlawat Pitsuwan, Dr. Ponlawat Pitsuwan, NIMH, NICE, WHO, SAMHSA, APA.